United States: Yearly Stock Market Performance Insight - 2003

Yearly Gainers
1,610
Yearly Losers
174
Average Return
80.38%
Total Stocks
1,850
View Detailed Market Cap Breakdown
Market Cap Yearly Gainers Yearly Losers Average Return Total Stocks
Mega Cap 32 2 46.89% 34
Large Cap 422 32 59.36% 463
Mid Cap 385 29 62.71% 427
Small Cap 130 20 63.96% 157

Yearly Streak Leaders for 2003

Stock Streak Streak Return
5 years โ†‘ 431.81%

UnitedHealth solidifies its market leadership with a 5-year growth streak (5.47 โ†’ 29.09), delivering 431.8% cumulative returns. With 109.6B annual revenue generating only 6.5B profit (5.9% margin) in Qtr ending Mar 2025, the market prices in significant margin expansion ahead.

3 years โ†‘ 77.49%

Bank of America maintains steady growth trajectory with a 3-year growth streak (22.66 โ†’ 40.22), delivering 77.5% cumulative returns. With 27.4B annual revenue generating only 7.4B profit (27.0% margin) in Qtr ending Mar 2025, the market prices in significant margin expansion ahead.

5 years โ†“ -50.70%

AT&T endures extended market pressure with a 5-year decline (39.94 โ†’ 19.69), down 50.7% cumulatively. Yet fundamentals remain solid: 30.6B annual revenue generating 4.7B profit (15.3% margin) as of Qtr ending Mar 2025 suggests this could be a value opportunity. Contrarian investors take note.

2 years โ†“ -12.29%

Johnson & Johnson sees continued yearly losses with a 2-year decline (58.90 โ†’ 51.66), down 12.3% cumulatively. Yet fundamentals remain solid: 21.9B annual revenue generating 11.0B profit (50.2% margin) as of Qtr ending Mar 2025 suggests this could be a value opportunity. Contrarian investors take note.

13 years โ†‘ 2,810.71%

Brown & Brown demonstrates exceptional long-term growth with a 13-year growth streak (0.28 โ†’ 8.15), delivering 2,810.7% cumulative returns. Annual financials validate this performance: 1.4B revenue generating 334.0M net profit (24.1% margin) demonstrates exceptional profit margins as of Qtr ending Mar 2025.

10 years โ†‘ 1,903.19%

Expeditors solidifies its market leadership with a 10-year growth streak (0.94 โ†’ 18.83), delivering 1,903.2% cumulative returns. With 2.7B annual revenue generating only 204.1M profit (7.7% margin) in Qtr ending Mar 2025, the market prices in significant margin expansion ahead.

8 years โ†“ -75.71%

Mosaic Company struggles through multi-year headwinds with a 8-year decline (40.88 โ†’ 9.93), down 75.7% cumulatively. The 2.6B annual revenue base faces margin compression with profits at 250.0M (Qtr ending Mar 2025). Market concerns about profitability trajectory drive the multi-year decline.

6 years โ†“ -43.19%

CNA Financial struggles through multi-year headwinds with a 6-year decline (42.42 โ†’ 24.10), down 43.2% cumulatively. Weak margins on 3.6B annual revenue with only 274.0M profit (7.7% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before recovery.

9 years โ†‘ 856.02%

Simpson continues its impressive multi-year expansion with a 9-year growth streak (2.66 โ†’ 25.43), delivering 856.0% cumulative returns. Annual financials validate this performance: 538.9M revenue generating 77.9M net profit (14.5% margin) demonstrates exceptional profit margins as of Qtr ending Mar 2025.

7 years โ†‘ 1,409.47%

Oshkosh continues its impressive multi-year expansion with a 7-year growth streak (1.69 โ†’ 25.51), delivering 1,409.5% cumulative returns. With 2.3B annual revenue generating only 112.2M profit (4.9% margin) in Qtr ending Mar 2025, the market prices in significant margin expansion ahead.

3 years โ†“ -81.64%

ASGN encounters consecutive annual declines with a 3-year decline (28.38 โ†’ 5.21), down 81.6% cumulatively. Weak margins on 968.3M annual revenue with only 20.9M profit (2.2% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before recovery.

3 years โ†“ -80.32%

Bruker encounters consecutive annual declines with a 3-year decline (23.12 โ†’ 4.55), down 80.3% cumulatively. Weak margins on 801.4M annual revenue with only 16.8M profit (2.1% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before recovery.

4 years โ†‘ 1,153.78%

BJ's Restaurants maintains steady growth trajectory with a 4-year growth streak (1.19 โ†’ 14.92), delivering 1,153.8% cumulative returns. With 348.0M annual revenue generating only 13.5M profit (3.9% margin) in Qtr ending Mar 2025, the market prices in significant margin expansion ahead.

4 years โ†‘ 686.86%

Pediatrix Medical shows consistent annual gains with a 4-year growth streak (1.75 โ†’ 13.77), delivering 686.9% cumulative returns. While annual revenue reaches 458.4M, net income of 20.7M (4.5% margin) in Qtr ending Mar 2025 shows the company prioritizes growth over margins - common for expanding Healthcare players.

4 years โ†“ -85.92%

Biolife Solutions endures extended market pressure with a 4-year decline (10.94 โ†’ 1.54), down 85.9% cumulatively. Financial struggles compound yearly losses: despite 23.9M annual revenue, - 448,000 losses persist (-1.9% margin) as of Qtr ending Mar 2025. Turnaround remains elusive.

3 years โ†“ -80.89%

Artivion encounters consecutive annual declines with a 3-year decline (30.25 โ†’ 5.78), down 80.9% cumulatively. Financial struggles compound yearly losses: despite 99.0M annual revenue, - 505,000 losses persist (-0.5% margin) as of Qtr ending Mar 2025. Turnaround remains elusive.

United States Market Yearly Gainers & Losers: 2003

Top United States Stock Gainers (2003)

Stock Year Open Year Close Yearly Change Avg Daily Volume Year Volume
$0.85 $3.91 394.94% 16.9M 4.3B
$0.96 $2.63 179.79% 180.8M 45.6B
$6.56 $14.90 130.65% 9.9M 2.5B
$0.10 $0.19 90.00% 972.1M 245.0B
$13.11 $24.23 84.96% 57.1M 14.4B
$0.34 $6.86 1,917.65% 2.3M 590.4M
$0.40 $3.76 817.07% 882.2K 222.3M
$0.65 $5.85 814.06% 182.7K 46.0M
$4.40 $29.70 575.00% 36.7K 9.3M
$1.80 $10.76 521.97% 2.4M 599.2M
$0.89 $9.18 931.46% 392.1K 98.8M
$0.32 $2.90 835.48% 20.2K 5.1M
$4.17 $29.85 615.83% 32.3K 8.1M
$1.00 $6.85 613.54% 92.0K 23.2M
$3.41 $16.88 411.52% 290.0K 73.1M
$2.73 $16.20 511.32% 145.7K 36.7M
$32.70 $138.60 360.47% 25.4K 6.4M
$1.55 $6.66 329.68% 44.8K 11.3M
$4.60 $19.23 322.64% 107.3K 27.0M
$0.86 $4.00 316.67% 38.6K 9.7M

Biggest United States Stock Losers (2003)

Stock Year Open Year Close Yearly Change Avg Daily Volume Year Volume
$21.07 $19.69 -3.86% 13.0M 3.3B
$54.25 $51.66 -3.82% 8.3M 2.1B
$2.90 $2.96 -85.13% 448.9K 113.1M
$7.74 $4.45 -42.80% 551.8K 139.1M
$16.03 $10.35 -34.70% 753.4K 189.9M
$18.55 $14.71 -20.53% 906.1K 228.3M
$14.60 $12.07 -18.78% 984.4K 248.1M
$24.02 $6.26 -72.68% 34.0K 8.6M
$26.35 $11.82 -54.95% 110.2K 27.8M
$8.64 $5.21 -38.85% 257.3K 64.8M
$5.70 $4.06 -28.01% 55.1K 13.9M
$5.40 $4.00 -25.93% 114.0K 28.7M
$0.13 $0.04 -69.23% 8.4K 2.1M
$2.57 $1.84 -27.84% 24.9K 6.3M
$6.75 $5.57 -18.80% 49.1K 12.4M
$29.28 $24.42 -18.60% 84.5K 21.3M
$77.25 $62.60 -16.37% 32.2K 8.1M

Most Active United States Stocks During 2003

Stock Year Open Year Close Yearly Change Avg Daily Volume Yearly Volume
$0.10 $0.19 90.00% 972.1M 245.0B
$0.26 $0.38 46.15% 282.7M 71.2B
$0.96 $2.63 179.79% 180.8M 45.6B
$26.15 $27.37 5.88% 65.1M 16.4B
$13.11 $24.23 84.96% 57.1M 14.4B
$16.02 $32.05 105.84% 57.1M 14.4B
$7.18 $13.60 90.48% 56.3M 14.2B
$4.25 $7.28 71.29% 30.3M 7.6B
$13.45 $22.44 72.22% 29.5M 7.4B
$18.31 $26.97 48.27% 24.4M 6.2B
$3.98 $5.88 48.11% 65.2M 16.4B
$6.36 $9.39 47.87% 40.8M 10.3B
$2.19 $11.14 408.68% 12.9M 3.3B
$11.47 $16.56 47.33% 6.3M 1.6B
$15.60 $23.21 49.55% 5.9M 1.5B
$4.83 $5.47 19.17% 4.3M 1.1B
$5.01 $4.60 -8.00% 4.2M 1.1B
$4.16 $10.78 160.39% 3.5M 889.3M
$5.63 $13.87 149.46% 3.4M 858.2M
$11.96 $17.68 47.33% 2.7M 674.4M

United States Sector Performance During 2003

Technology

129.81%
258 stocks
Top Performers by Market Cap:

Healthcare

125.22%
214 stocks
Top Performers by Market Cap:

Consumer Cyclical

86.68%
223 stocks
Top Performers by Market Cap:

Basic Materials

80.57%
99 stocks
Top Performers by Market Cap:
Mega Cap: LIN +32.23%
Large Cap: MT +303.18%
Small Cap: MTRN +178.36%

Industrials

71.12%
292 stocks
Top Performers by Market Cap:

Energy

65.91%
83 stocks
Top Performers by Market Cap:
Mega Cap: CVX +29.96%
Large Cap: LNG +814.06%
Small Cap: WKC +65.82%

Consumer Defensive

64.56%
95 stocks
Top Performers by Market Cap:
Mega Cap: COST +32.50%
Large Cap: MNST +125.00%
Small Cap: SPB +89.86%

Communication Services

60.78%
56 stocks
Top Performers by Market Cap:
Mega Cap: NFLX +394.94%
Large Cap: EA +91.56%
Small Cap: STGW +168.07%

Real Estate

59.94%
96 stocks
Top Performers by Market Cap:

Financial Services

46.64%
359 stocks
Top Performers by Market Cap:
Mega Cap: JPM +53.04%
Large Cap: COF +106.22%
Small Cap: BLX +322.64%

Utilities

35.09%
57 stocks
Top Performers by Market Cap:
Large Cap: EVRG +104.55%
Small Cap: MSEX +29.05%

Data is updated regularly. Yearly performance is calculated based on closing prices.